| PJGCX | RWMHX | PJGCX / RWMHX | |
| Total Expense Ratio | 2.24 | 0.41 | 546% |
| Annual Report Gross Expense Ratio | 2.24 | 0.41 | 546% |
| Fund Existence | 29 years | 10 years | - |
| Gain YTD | 2.620 | 2.169 | 121% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 299M | 208B | 0% |
| Annual Yield % from dividends | 0.33 | 1.38 | 24% |
| Returns for 1 year | 5.34 | 9.89 | 54% |
| Returns for 3 years | 14.38 | 31.32 | 46% |
| Returns for 5 years | 16.43 | 39.60 | 42% |
| Returns for 10 years | 4.11 | 101.22 | 4% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 41.49 | 1.67 | +4.19% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| KXI | 66.96 | 0.76 | +1.15% |
| iShares Global Consumer Staples ETF | |||
| VTV | 197.68 | 1.09 | +0.55% |
| Vanguard Value ETF | |||
| AFIF | 9.45 | N/A | -0.05% |
| Anfield Universal Fixed Income ETF | |||
| DMAX | 26.67 | -0.03 | -0.12% |
| iShares Large Cap Max Buffer Dec ETF | |||